40371-52-6

Basic information

• Product Name: Carbamic acid, [4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-hydroxy-4-oxobutyl]-, phenylmethyl ester, (S)-
• CAS NO: 40371-52-6
• Molecular Formula: C16H18N2O7
• Molecular Weight: 350.328
• Mol File: 40371-52-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Carbamic acid, [4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-hydroxy-4-oxobutyl]-, phenylmethyl ester, (S)-(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-hydroxy-4-oxobutyl]-, phenylmethyl ester, (S)-(40371-52-6)
• EPA Substance Registry System: Carbamic acid, [4-[(2,5-dioxo-1-pyrrolidinyl)oxy]-3-hydroxy-4-oxobutyl]-, phenylmethyl ester, (S)-(40371-52-6)

Safety Data

• Hazardous Substances Data: 40371-52-6(Hazardous Substances Data)

Upstream product

• 6066-82-6 1-hydroxy-pyrrolidine-2,5-dione 
• 40371-50-4 S-4-benzyloxycarbonylamino-2-hydroxybutyric acid 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 1261084-79-0 C₃₁H₃₉N₃O₉ 
• 1312471-07-0 6'-N-CbzAHB tobramycin 
• 1312471-08-1 6'''-N-CbzAHB paromomycin 
• 940286-42-0 2-O-allyl-tetra-tert-butyldimethylsilanyloxy-penta-N-benzyloxycarbonyl-3',4'-dideoxy-N-1-haba-paromomycin 
• 419573-56-1 1-N-[(S)-4-(benzyloxycarbonylamino)-2-hydroxybutanoyl]-6-O-[2-N-[4-(benzyloxycarbonyl)butylamino]ethylamino]-3,2',6'-tris(N-benzyloxycarbonyl)neamine 
• 419573-55-0 1-N-[(S)-4-(benzyloxycarbonylamino)-2-hydroxybutanoyl]-6-O-[2-N-[3-(benzyloxycarbonyl)propylamino]ethylamino]-3,2',6'-tris(N-benzyloxycarbonyl)neamine 
• 419573-54-9 1-N-[(S)-4-(benzyloxycarbonylamino)-2-hydroxybutanoyl]-6-O-[2-N-(2-(benzyloxycarbonyl)ethylamino)ethylamino]-3,2',6'-tris(N-benzyloxycarbonyl)neamine 

Relevant articles and documents

Synthesis and Biological Activity of Mono- and Di-N-acylated Aminoglycosides

Despite issues with oto/nephrotoxicity and bacterial resistance, aminoglycosides (AGs) remain an effective and widely used class of antibacterial agents. For decades now, efforts toward the development of novel AGs with potential to overcome some of these

Design of novel antibiotics that bind to the ribosomal acyltransfer site

The structure of neamine bound to the A site of the bacterial ribosomal RNA was used in the design of novel aminoglycosides. The design took into account stereo and electronic contributions to interactions between RNA and aminoglycosides, as well as a ran